Fingerprint
Dive into the research topics of 'The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin - The Aprepitant Protocol 052 Study Group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically